Next Article in Journal
Development of a Microfluidic Array to Study Drug Response in Breast Cancer
Previous Article in Journal
Oroxin B Induces Apoptosis by Down-Regulating MicroRNA-221 Resulting in the Inactivation of the PTEN/PI3K/AKT Pathway in Liver Cancer
Previous Article in Special Issue
Curcumin Derivatives Verify the Essentiality of ROS Upregulation in Tumor Suppression
Open AccessReview

Curcumin and Its Derivatives as Potential Therapeutic Agents in Prostate, Colon and Breast Cancers

Department of Chemistry, University of Fort Hare, Alice Campus, Alice 5700, Eastern Cape, South Africa
*
Author to whom correspondence should be addressed.
Academic Editors: Erika Ferrari and Carol Imbriano
Molecules 2019, 24(23), 4386; https://doi.org/10.3390/molecules24234386
Received: 30 August 2019 / Revised: 27 September 2019 / Accepted: 3 October 2019 / Published: 30 November 2019
(This article belongs to the Special Issue Curcumin)
Cancer is a life-threatening disease and is the second leading cause of death around the world. The increasing threats of drug-resistant cancers indicate that there is an urgent need for the improvement or development of more effective anticancer agents. Curcumin, a phenolic compound originally derived from turmeric plant (Curcuma longa L. (Zingiberaceae family)) widely known as a spice and a coloring agent for food have been reported to possess notable anticancer activity by inhibiting the proliferation and metastasis, and enhancing cell cycle arrest or apoptosis in various cancer cells. In spite of all these benefits, the therapeutic application of curcumin in clinical medicine and its bioavailability are still limited due to its poor absorption and rapid metabolism. Structural modification of curcumin through the synthesis of curcumin-based derivatives is a potential approach to overcome the above limitations. Curcumin derivatives can overcome the disadvantages of curcumin while enhancing the overall efficacy and hindering drug resistance. This article reports a review of published curcumin derivatives and their enhanced anticancer activities. View Full-Text
Keywords: curcumin; anticancer activity; derivatives of curcumin; drug resistance; breast cancer; prostate cancer; colon cancer curcumin; anticancer activity; derivatives of curcumin; drug resistance; breast cancer; prostate cancer; colon cancer
Show Figures

Graphical abstract

MDPI and ACS Style

Mbese, Z.; Khwaza, V.; Aderibigbe, B.A. Curcumin and Its Derivatives as Potential Therapeutic Agents in Prostate, Colon and Breast Cancers. Molecules 2019, 24, 4386.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop